- Case report
- Open Access
Duodenal obstruction - an unusual presentation of Strongyloides stercoralis enteritis: a case report
© Cruz et al; licensee BioMed Central Ltd. 2010
- Received: 21 May 2010
- Accepted: 10 August 2010
- Published: 10 August 2010
Intestinal obstruction is a poorly recognized and probably underreported complication of strongyloidiasis. We present herein an unusual case, of complete duodenal obstruction caused by S. stercoralis.
A systematic review of the literature examining the clinical course, diagnostic methods, and outcome of this rare complication of strongyloidiasis was performed.
A 42-year-old woman presented with a 5-month history of abdominal pain, vomit, and weight loss. An abdominal CT scan showed an obstruction of the third part of the duodenum. Segmental intestinal resection was carried out and histopathology examination revealed heavy Strongyloides stercoralis infestation. Duodenal obstruction is a rare complication of S. stercoralis infection, with only 8 cases described in the literature since 1970. Most of the patients are males, middle-aged, and the diagnosis was made by duodenal aspirate/biopsy, or analysis of surgical specimen.
Duodenal obstruction is an unusual, but potential fatal, complication of S. stercoralis infection. The large spectrum of clinical manifestation and lack of classic clinical syndrome make the final diagnosis of strongyloidiasis extremely difficult. A high index of suspicion, mainly in patients from endemic areas, is needed for correct and early diagnosis of this uncommon presentation of Strogyloides stercoralis enteritis.
- Gastrointestinal Stromal Tumor
- Infective Larva
Strongyloidiasis is a parasitic disease, caused by a nematode helminth, Strongyloides stercoralis. The true prevalence of S. stercoralis is likely underestimated because infection is often subclinical [1–3]. Currently, an estimated 100 million people are infected worldwide in more than 70 countries. Strongyloidiasis is endemic in Southeast Asia, Latin America, Sub-Saharan Africa, and parts of the southeastern United States [3–6]. Typically, the infection is asymptomatic or manifest as vague and unspecific gastrointestinal symptoms. However, disseminated infestation of infective larvae is associated with high mortality rates in immunocompromised patients [3, 7].
Intestinal obstruction is a poorly recognized and probably underreported complication of strongyloidiasis. Herein, we report an unusual case, of complete duodenal obstruction caused by S. stercoralis. Additionally, we performed a systematic review of the literature examining the clinical course, diagnostic methods, management and outcome of this rare, but potential fatal complication of S. stercoralis infection.
A review of literature was performed using the MEDLINE database in order to identify articles of duodenal obstruction caused by Strongyloides stercolaris. Inclusion was limited to cases reported in adults, and published in the English language since 1970. All the articles were systematically reviewed and only cases of confirmed duodenal obstruction were included in this report.
A 42-year-old woman presented with a 5-month history of recurrent abdominal pain, nausea, post-prandial vomiting, intermittent diarrhea, and a 20 Kg (44 lb) weight loss. Her past medical history was unremarkable, except for an admission for pneumonia in the past year. On physical examination the patient was in poor clinical condition, malnourished, afebrile, with a blood pressure of 100/40 mmHg, pulse of 100 beats per minute and a respiratory rate of 24 breaths per minute. No lymphadenophaty was found. The lungs were clear and the heart was normal on auscultation. Abdominal examination revealed epigastric distention, without guarding or rebound tenderness. The spleen and liver were not palpated and a mild pedal edema was observed.
Stools tested for occult blood were positive, and negative for ova and parasites. Laboratory evaluation revealed a hematocrit of 39%, white blood cell count of 14.9 × 103/L (bands 8%, neutrophils 73%, lynphocytes 12%, and eosinophils 0%), and platelet count of 600 × 103/μL. Total serum protein and albumin levels were 2.9 g/dL and 1.2 g/dL, respectively. Serum creatinine was 2.5 mg/dL, BUN 118 mg/dL, and potassium 2.8 mMol/L. Liver function tests, amylase and lipase were within normal limits. She had a positive serology for toxoplasmosis (IgM antibody), but negative for HIV, and HTLV-1.
At this point we decided to start the patient on total parenteral nutrition and repeat the upper endoscopy in 48 hours. Despite clinical support, 24 hours after admission, the patient presented a significant worsening of the abdominal pain, fever, increasing white blood cell count, and intermittent hypotension requiring additional intravenous fluid bolus. Based on the abdominal CT findings, we suspected of the presence of a complicated submucosal duodenal tumor, such as a primary intestinal lymphoma or gastrointestinal stromal tumor, and decided to take the patient to the operating room.
Strongyloidiasis is a common intestinal infection caused by two species of the nematode Strongyloides. The most common and clinically important pathogenic species in humans is Strongyloides stercoralis. The other specie, Strongyloides fuelleborni, is found sporadically in Africa and may produce limited infections in humans [3, 8]. Strongyloidiasis was first described in 1876, in French colonial troops suffering from diarrhea in Vietnam .
The complete elucidation of the parasite's life cycle occurred 50 years after its identification. This fact is probably related to the unique and complex life cycle of the parasite. Strongyloides stercoralis larvae exist in two forms: free-living rhabditiform and filariform infective larvae. The cycle starts with the infectious filariform larvae penetrating the skin and traveling via lymphatics or bloodstream to the lungs. After penetrating in the alveoli the larvae continue to migrate up to the airways until they are swallowed. In the duodenum and proximal jejunum the larvae mature into adult females which live threaded in the intestinal mucosa. The larvae can produce up to 40 eggs a day by mitotic parthenogenesis (i.e., asexual reproduction where development of embryos occurs without fertilization by a male). Once these eggs hatch, rhabditiform larvae are released. These larvae can either passed in the stools, continuing the soil based cycle, or can cause autoinfection. The autoinfection occurs when the rhabditiform larvae prematurely become the infective filariform larvae in the intestinal lumen, and penetrate in the intestinal mucosa or perianal skin (internal and external autoinfection, respectively). In either case the infective larvae migrate to the lungs and restart the cycle previously described [1, 3, 7]. The autoinfection phenomenon allows S. stercoralis to persist and replicate within a host for decades, with the longest reported period being 65 years .
The term "disseminated disease" is used to define when the infective larvae migrate, from the intestine, in massive numbers not only to the lungs but to other organs not involved in the normal helminthic life cycle. In disseminated strongyloidiasis, the mortality rate can be as high as 70-90% . Several risk factors are associated with the development of disseminated strongyloidiasis, including (1) immune deficiency, (2) hematologic malignacy, (3) steroids administration, (4) HTLV-1 infection, (5) chronic alcoholism, (6) renal failure, (7) transplantation, among others . In disseminated disease, translocation of enteric bacteria may occur, leading to Gram-negative sepsis and/or meningitis. The enteric microorganism can either enter the circulation through intestinal ulcers or be carried by the infective filariform larvae.
Approximately, half of Strongyloides infections are asymptomatic [1, 3]. Clinical presentation is extremely variable reflecting the complex life cycle of the parasite. When symptoms develop, gastrointestinal complaints are common. Symptoms are vague and nonspecific and include anorexia, nausea, vomiting, weight loss, abdominal pain, flatulence, and diarrhea. Less frequently, malabsorption syndromes, paralytic ileus, intestinal obstruction and gastrointestinal bleeding, may occur [1–3]. Pulmonary symptoms are rare in uncomplicated strongyloidiasis, but cough and wheezing may be part of initial presentation (Löffler's syndrome). In disseminated disease respiratory symptoms become more prominent and include dyspnea, tachypnea, pleuritic pain, pleural effusion, and hemoptysis [1, 2, 6]. Larva currens (racing larvae) is the pathognomonic cutaneus manifestation of Strongyloidis infection that usually occurs during an external autoinfection episode. The serpiginous urticarial rash is caused by rapid (approximatelly 15 cm/h) moving of Strongyloides stercoralis larvae from the anal area down the upper thighs [3, 12].
Literature review of duodenal obstruction caused by Strongyloides stercoralis infection (1970-2010).
Cohen & Spry13
Zyngier et al.14
Lee & Terry15
Friedenberg et al.16
Harish et al.9
Suvarna et al.17
Juchems et al.18
ivermectin + albendazole
Paralytic ileus is also a potential complication of S. stercolaris hyperinfection [7, 11, 20–23]. In a recent review, Yoshida et al. have reported 25 cases of Strongyloides-related ileus . Most of the patients were males (60%) and middle-aged, findings similar to patients with duodenal obstruction (Table 1). Despite unavailable data in the literature, it seems that obstructive gastrointestinal symptoms are more common in this specific group of patients, since the infection has no predilection for either sex or age.
Strongyloidiasis is usually associated with anemia, hypocholesterolemia and hypoalbuminemia. Eosinophilia is an inconsistent finding, present in up to 35% during the acute phase, and less frequent in patients with chronic or disseminated disease. Most patients with duodenal obstruction presented low eosinophil count indicating a chronic infection. Eosinopenia and low IgE level have been associated with a poor prognosis, in patients with disseminated disease [3, 11].
Duodenal obstruction may be caused by different diseases, including tuberculosis, primary intestinal lymphoma, Crohn's disease, eosinophilic gastroenteritis and gastrointestinal stromal tumor. Despite extensive preoperative work-up, three out of the nine cases presented in Table 1, the diagnosis was made after exploratory laparotomy. Therefore, a high index of suspicion is essential for correct diagnosis of Strongyloides-related duodenal obstruction. The diagnosis of strongyloidiasis may be confirmed by the presence of the larvae in the stools. This is an easy performed, broadly available and inexpensive method for detection of the parasite. However, stool examination is relatively insensitive, and diagnostic yield of a single specimen is approximately 30%. The sensitivity of fecal smear could be increased to up to 60%, if five or more stool samples are examined . Of note, S. stercoralis is the only helminth that secretes larvae in the stools. Thus, the presence of eggs in the fecal smear is unlikely.
Other methods such as duodenal aspirate or biopsy are more invasive therefore less desirable. Nevertheless, it has been shown that the examination of a duodenal aspirate for ova and larvae is the most sensitive diagnostic procedure, with a false-negative frequency of less than 10% [24, 25]. Endoscopic findings include duodenal mucosal edema, erythema, hemorrhagic spots, ulcerations, and in some cases megaduodenum. Duodenal white villi is also a common endoscopic feature, and should alert the physician for the diagnosis of strongyloidiasis [25, 26]. Recently, Kishimoto et al. showed that the S. stercoralis larvae identification in duodenal biopsies is feasible in 71% of cases . In eight out of the nine cases presented in Table 1, the diagnosis was made by duodenal aspirate/biopsy, or analysis of surgical specimen. These findings confirmed the poor reliability of stool analysis for the parasite identification
In cases of disseminated infection, the parasite can be also identified in sputum, broncho-alveolar lavage, cerebrospinal fluid, skin, urine, and ascites . Serology tests are indicated when the infection is suspected and the S. stercoralis cannot be demonstrated by the standard diagnostic evaluation. Although, indirect hemmagglutination (IHA) and indirect fluorescent antibody (IFA) test have been used, enzyme-linked immunosorbent assay (ELISA) is currently recommended because of its greater sensitivity [8, 28, 29]. Despite its high specificity and sensitivity, immunodiagnostic tests have certain limitations, including: (1) variable reliability in different commercial kits available, (2) falsely negative results in immunocompromised hosts, (3) the presence of anti-strongyloides antibody for a long period of time, even after successful treatment, and (4) falsely positive results due to cross-reactions with other parasitic infections such as filariasis and acute schistosomiasis [3, 8].
Imaging studies are nonspecific. However, radiological abnormalities restricted to the duodenum and proximal jejunum, on CT scans and upper gastrointestinal series, should alert the surgeon to the possibility of strongyloidiasis. A unique radiographic feature of strongyloidiasis is the reflux of oral contrast into the biliary tree, possibly due to an incompetent sphincter of Oddi caused by severe inflammation of the duodenal wall .
Medical treatment should be achieved even in the absence of symptoms, in order to avoid the dissemination of the parasite and minimize the risk of development hyperinfection syndrome. The drug of choice for treatment of strongyloidiasis is ivermectin given at a dose of 200 mcg/kg of body weight daily for at least 2 days [3, 8, 31]. In cases of disseminated disease it may be necessary to prolong or repeat therapy. Albendazole and thiabendazole, are equivalent to ivermectin in efficacy. However, thiabendazole is associated with frequent and severe side effects, and has not been longer recommended for systemic infection in HIV-patients . Due to a critical condition of our patient we decided to use a combination therapy of albendazole and ivermectin. This therapeutic strategy has been recommended for the treatment of disseminated strongyloidiasis with good results [3, 8, 25].
In patients who are not able to tolerate oral treatment, rectal administration of ivermectin or thiabendazole has been suggested [32, 33]. However, recent reports have shown that serum ivermectin concentration is very low after rectal administration in patients sustaining paralytic ileus or intestinal obstruction [34, 35]. No parenteral preparation of these anthelmintics is available for use in humans, although subcutaneous veterinary ivermectin has been utilized successfully in the treatment of strongyloidiasis unresponsive to standard oral therapy or when enteral administration is not feasible [34–36]. Thus, further studies assessing safety, efficacy and pharmacokinetics of parenteral ivermectin are needed in order improve the treatment and outcome of patients sustaining this unusual complication of Strongyloides stercoralis hyperinfection.
In summary, duodenal obstruction is a rare, but potential fatal, complication of S. stercoralis infection. The large spectrum of clinical manifestation and lack of classic clinical syndrome make the final diagnosis of strongyloidiasis extremely difficult. Therefore a high index of suspicion, mainly in patients from endemic areas, is needed for correct and early diagnosis of this uncommon complication of Strogyloides stercoralis infection.
Written informed consent was obtained from the patient's family for publication of this case report and any accompanying images. A copy of the written consent is available for review by the Editor-in-Chief of this journal.
- Concha R, Harrington W, Rogers AI: Intestinal strongyloidiasis: recognition, management, and determinants of outcomes. J Clin Gastroenterol. 2005, 39: 203-211. 10.1097/01.mcg.0000152779.68900.33.View ArticlePubMedGoogle Scholar
- Mahmoud AA: Strongyloidiasis. Clin Infect Dis. 1996, 23 (5): 949-952.View ArticlePubMedGoogle Scholar
- Segarra-Newnham M: Manifestations, diagnosis, and treatment of Strongyloides stercoralis infection. Ann Pharmacother. 2007, 41 (12): 1992-2001. 10.1345/aph.1K302.View ArticlePubMedGoogle Scholar
- Olsen A, van Lieshout L, Marti H, Polderman T, Polman K, Steinmann P, Stothard R, Thybo S, Verweij JJ, Magnussen P: Strongyloidiasis: the most neglected of the neglected tropical diseases?. Trans R Soc Trop Med Hyg. 2009, 103 (10): 967-972. 10.1016/j.trstmh.2009.02.013.View ArticlePubMedGoogle Scholar
- Genta RM: Global prevalence of strongyloidiasis: critical review with epidemiologic insights into the prevention of disseminated disease. Rev Infect Dis. 1989, 11 (5): 755-767.View ArticlePubMedGoogle Scholar
- Chu E, Whitlock WL, Dietrich RA: Pulmonary hyperinfection syndrome with Strongyloides stercoralis. Chest. 1990, 97 (6): 1475-1477. 10.1378/chest.97.6.1475.View ArticlePubMedGoogle Scholar
- Ramdial PK, Hlatshwayo NH, Singh B: Strongyloides stercoralis mesenteric lymphadenopathy: clue to the etiopathogenesis of intestinal pseudo-obstruction in HIV-infected patients. Ann Diagn Pathol. 2006, 10 (4): 209-214. 10.1016/j.anndiagpath.2005.11.008.View ArticlePubMedGoogle Scholar
- CDC Parisitology Diagnostic website. [http://www.dpd.cdc.gov/dpdx/HTML/Strongyloidiasis.htm]
- Harish K, Sunilkumar R, Varghese T, Feroze M: Strongyloidiasis presenting as duodenal obstruction. Trop Gastroenterol. 2005, 26 (4): 201-202.PubMedGoogle Scholar
- Leighton PM, MacSween HM: Strongyloides stercoralis. The cause of an urticarial-like eruption of 65 years' duration. Arch Intern Med. 1990, 150 (8): 1747-1748. 10.1001/archinte.150.8.1747.View ArticlePubMedGoogle Scholar
- Yoshida H, Endo H, Tanaka S, Ishikawa A, Kondo H, Nakamura T: Recurrent paralytic ileus associated with strongyloidiasis in a patient with systemic lupus erythematosus. Mod Rheumatol. 2006, 16 (1): 44-47. 10.1007/s10165-005-0447-1.View ArticlePubMedGoogle Scholar
- Galimberti R, Pontón A, Zaputovich FA, Velasquez L, Galimberti G, Torre A, Kowalczuk A: Disseminated strongyloidiasis in immunocompromised patients--report of three cases. Int J Dermatol. 2009, 48 (9): 975-978. 10.1111/j.1365-4632.2009.04082.x.View ArticlePubMedGoogle Scholar
- Cohen J, Spry CJ: Strongyloides stercoralis infection and small intestinal lymphoma. Parasite Immunol. 1979, 1 (2): 167-178. 10.1111/j.1365-3024.1979.tb00704.x.View ArticlePubMedGoogle Scholar
- Zyngier FR, Lemme A, Pereira EG, Leal BB, Liberal MH: Surgical perpetuation of serious infection with Strongyloides stercoralis. Trans R Soc Trop Med Hyg. 1983, 77 (3): 425-10.1016/0035-9203(83)90182-7.View ArticlePubMedGoogle Scholar
- Lee MG, Terry SI: Arteriomesenteric duodenal occlusion associated with strongyloidiasis. J Trop Med Hyg. 1989, 92 (1): 41-45.PubMedGoogle Scholar
- Friedenberg F, Wongpraparut N, Fischer RA, Gubernick J, Zaeri N, Eiger G, Ozden Z: Duodenal obstruction caused by Strongyloides stercoralis enteritis in an HTLV-1-infected host. Dig Dis Sci. 1999, 44 (6): 1184-1188. 10.1023/A:1026636509713.View ArticlePubMedGoogle Scholar
- Suvarna D, Mehta R, Sadasivan S, Raj VV, Balakrishnan V: Infiltrating Strongyloides stercoralis presenting as duodenal obstruction. Indian J Gastroenterol. 2005, 24 (4): 173-174.PubMedGoogle Scholar
- Juchems MS, Niess JH, Leder G, Barth TF, Adler G, Brambs HJ, Wagner M: Strongyloides stercoralis: a rare cause of obstructive duodenal stenosis. Digestion. 2008, 77 (3-4): 141-144. 10.1159/000128597.View ArticlePubMedGoogle Scholar
- Stemmermann GN: Strongyloidiasis in migrants. Pathological and clinical considerations. Gastroenterology. 1967, 53 (1): 59-70.PubMedGoogle Scholar
- Al Maslamani MA, Al Soub HA, Al Khal AL, Al Bozom IA, Abu Khattab MJ, Chacko KC: Strongyloides stercoralis hyperinfection after corticosteroid therapy: a report of two cases. Ann Saudi Med. 2009, 29 (5): 397-401. 10.4103/0256-4947.55172.PubMed CentralView ArticlePubMedGoogle Scholar
- Bannon JP, Fater M, Solit R: Intestinal ileus secondary to Strongyloides stercoralis infection: case report and review of the literature. Am Surg. 1995, 61 (4): 377-380.PubMedGoogle Scholar
- Al-Bahrani ZR, Al-Saleem T, Al-Gailani MA: Sub-acute intestinal obstruction by Strongyloides stercolaris. J Infect. 1995, 30 (1): 47-50. 10.1016/S0163-4453(95)92847-2.View ArticlePubMedGoogle Scholar
- Nonaka D, Takaki K, Tanaka M, Umeno M, Takeda T, Yoshida M, Haraguch Y, Okada K, Sawae Y: Paralytic ileus due to strongyloidiasis: case report and review of the literature. Am J Trop Med Hyg. 1998, 59 (4): 535-538.PubMedGoogle Scholar
- James CA, Abadie SH: Studies in human strongyloides II. A comparison of the efficiency of diagnosis by examination of feces and duodenal fluid. Am J Clin Pathol. 1954, 24: 1154-1158.Google Scholar
- Lim S, Katz K, Krajden S, Fuksa M, Keystone JS, Kain KC: Complicated and fatal Strongyloides infection in Canadians: risk factors, diagnosis and management. CMAJ. 2004, 171: 479-484.PubMed CentralView ArticlePubMedGoogle Scholar
- Thompson BF, Fry LC, Wells CD, Olmos M, Lee DH, Lazenby AJ, Mönkemüller KE: The spectrum of GI strongyloidiasis: an endoscopic-pathologic study. Gastrointest Endosc. 2004, 59 (7): 906-910. 10.1016/S0016-5107(04)00337-2.View ArticlePubMedGoogle Scholar
- Kishimoto K, Hokama A, Hirata T, Ihama Y, Nakamoto M, Kinjo N, Kinjo F, Fujita J: Endoscopic and histopathological study on the duodenum of Strongyloides stercoralis hyperinfection. World J Gastroenterol. 2008, 14 (11): 1768-1773. 10.3748/wjg.14.1768.PubMed CentralView ArticlePubMedGoogle Scholar
- Genta RM: Predictive value of an enzyme-linked immunosorbent assay (ELISA) for the serodiagnosis of strongyloidiasis. Am J Clin Pathol. 1988, 89 (3): 391-394.PubMedGoogle Scholar
- Lindo JF, Conway DJ, Atkins NS, Bianco AE, Robinson RD, Bundy DA: Prospective evaluation of enzyme-linked immunosorbent assay and immunoblot methods for the diagnosis of endemic Strongyloides stercoralis infection. Am J Trop Med Hyg. 1994, 51 (2): 175-179.PubMedGoogle Scholar
- Louisy CL, Barton CJ: The radiological diagnosis of Strongyloides stercoralis enteritis. Radiology. 1971, 98 (3): 535-541.View ArticlePubMedGoogle Scholar
- Datry A, Hilmarsdottir I, Mayorga-Sagastume R, Lyagoubi M, Gaxotte P, Biligui S, Chodakewitz J, Neu D, Danis M, Gentilini M: Treatment of Strongyloides stercoralis infection with ivermectin compared with albendazole: results of an open study of 60 cases. Trans R Soc Trop Med Hyg. 1994, 88 (3): 344-345. 10.1016/0035-9203(94)90110-4.View ArticlePubMedGoogle Scholar
- Boken DJ, Leoni PA, Preheim LC: Treatment of Strongyloides stercoralis hyperinfection syndrome with thiabendazole administered per rectum. Clin Infect Dis. 1993, 16 (1): 123-126.View ArticlePubMedGoogle Scholar
- Tarr PE, Miele PS, Peregoy KS, Smith MA, Neva FA, Lucey DR: Case report: Rectal adminstration of ivermectin to a patient with Strongyloides hyperinfection syndrome. Am J Trop Med Hyg. 2003, 68 (4): 453-455.PubMedGoogle Scholar
- Grein JD, Mathisen GE, Donovan S, Fleckenstein L: Serum ivermectin levels after enteral and subcutaneous administration for Strongyloides hyperinfection: a case report. Scand J Infect Dis. 2010, 42: 234-236. 10.3109/00365540903443165.View ArticlePubMedGoogle Scholar
- Chiodini PL, Reid AJ, Wiselka MJ, Firmin R, Foweraker J: Parenteral ivermectin in Strongyloides hyperinfection. Lancet. 2000, 355: 43-44. 10.1016/S0140-6736(99)02744-0.View ArticlePubMedGoogle Scholar
- Lichtenberger P, Rosa-Cunha I, Morris M, Nishida S, Akpinar E, Gaitan J, Tzakis A, Doblecki-Lewis S: Hyperinfection strongyloidiasis in a liver transplant recipient treated with parenteral ivermectin. Transpl Infect Dis. 2009, 11: 137-142. 10.1111/j.1399-3062.2008.00358.x.View ArticlePubMedGoogle Scholar
This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.